NASDAQ:HSIC - Henry Schein Stock Price, Forecast & News

Henry Schein's stock was trading at $57.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, HSIC stock has decreased by 13.9% and is now trading at $49.65. View which stocks have been mosted impacted by Coronavirus.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 3 sell ratings, 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Henry Schein.

Henry Schein is scheduled to release its next quarterly earnings announcement on Tuesday, May 5th 2020. View our earnings forecast for Henry Schein.

Henry Schein, Inc. (NASDAQ:HSIC) issued its quarterly earnings results on Thursday, February, 20th. The company reported $0.97 EPS for the quarter, topping the Zacks' consensus estimate of $0.91 by $0.06. The business had revenue of $2.67 billion for the quarter, compared to analyst estimates of $2.64 billion. Henry Schein had a net margin of 6.96% and a return on equity of 15.01%. The company's revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the business earned $1.12 earnings per share. View Henry Schein's earnings history.

Shares of Henry Schein split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly minted shares were payable to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

Henry Schein declared that its board has authorized a share repurchase plan on Thursday, October 31st 2019, which allows the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to reacquire up to 4.3% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's management believes its stock is undervalued.

Henry Schein issued an update on its FY20 earnings guidance on Thursday, February, 20th. The company provided earnings per share (EPS) guidance of $3.65 to $3.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.70.

13 equities research analysts have issued twelve-month target prices for Henry Schein's shares. Their forecasts range from $57.00 to $80.00. On average, they expect Henry Schein's share price to reach $70.50 in the next year. This suggests a possible upside of 42.0% from the stock's current price. View analysts' price targets for Henry Schein.

News coverage about HSIC stock has been trending very negative this week, according to InfoTrie. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Henry Schein earned a news impact score of -3.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future. View the latest news aboutHenry Schein.

Henry Schein saw a decrease in short interest in March. As of March 13th, there was short interest totaling 14,347,300 shares, a decrease of 10.9% from the February 27th total of 16,100,000 shares. Based on an average trading volume of 2,173,700 shares, the short-interest ratio is currently 6.6 days. Currently, 10.2% of the company's shares are short sold. View Henry Schein's Current Options Chain.

Some companies that are related to Henry Schein include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Patterson Companies (PDCO) and Owens & Minor (OMI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), NVIDIA (NVDA), Walt Disney (DIS), Micron Technology (MU), AbbVie (ABBV), Boeing (BA), UnitedHealth Group (UNH), Amgen (AMGN), salesforce.com (CRM) and AT&T (T).

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of HSIC stock can currently be purchased for approximately $49.65.

Henry Schein has a market capitalization of $7.12 billion and generates $9.99 billion in revenue each year. The company earns $694.73 million in net income (profit) each year or $3.51 on an earnings per share basis. Henry Schein employs 19,000 workers across the globe. View additional information about Henry Schein.

The official website for Henry Schein is http://www.henryschein.com/.

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]